A Phase IB Study Of Oral SCH 66336 Preoperatively In Patients With Head And Neck Squamous Cell Cancer
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
SCH66336 is a drug that has been designed to block the growth of tumor cells and encourage
tumor cell death.
This is a randomized study where patients will receive study drug or no drug. Participants in
this study are scheduled to have surgery to remove head and neck cancer.